BCM
BDSX icon

Bridgeway Capital Management’s Biodesix BDSX Stock Holding History

Bridgeway Capital Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$160K Buy
+11,035
New +$137K ﹤0.01% 1069
2025
Q3 		– Sell
-6,851
Closed -$38.7K – 1203
2025
Q2 		$38.7K Hold
6,851
– – ﹤0.01% 1144
2025
Q1 		$85.7K Sell
6,851
-12,865
-65% -$247K ﹤0.01% 1066
2024
Q4 		$603K Buy
19,716
+5,490
+39% +$162K 0.01% 776
2024
Q3 		$506K Buy
14,226
+4,973
+54% +$171K 0.01% 857
2024
Q2 		$283K Sell
9,253
-2,230
-19% -$63.7K 0.01% 976
2024
Q1 		$328K Buy
11,483
+23
+0.2% +$787 0.01% 1021
2023
Q4 		$422K Buy
11,460
+2,460
+27% +$77.2K 0.01% 981
2023
Q3 		$297K Sell
9,000
-2,500
-22% -$69.4K 0.01% 1012
2023
Q2 		$283K Buy
11,500
+2,530
+28% +$75.8K 0.01% 1061
2023
Q1 		$334K Buy
8,970
+5,220
+139% +$214K 0.01% 984
2022
Q4 		$173K Sell
3,750
-1,250
-25% -$34K ﹤0.01% 1117
2022
Q3 		$127K Buy
5,000
+2,500
+100% +$96.4K ﹤0.01% 1229
2022
Q2 		$82K Sell
2,500
-1,750
-41% -$56.9K ﹤0.01% 1247
2022
Q1 		$144K Sell
4,250
-1,000
-19% -$65.4K ﹤0.01% 1224
2021
Q4 		$555K Buy
+5,250
New +$686K 0.01% 951

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Bridgeway Capital Management's BDSX Position: Q1 2026 in Review

Bridgeway Capital Management opened a new position in Biodesix (BDSX) in Q1 2026: 11,035 shares worth $160K. The stake represents ﹤0.01% of the portfolio and ranks #1069 among its holdings. This is a return to the name: Bridgeway Capital Management previously reported a position in BDSX as recently as Q2 2025.

Bridgeway Capital Management first reported a position in BDSX in Q4 2021 and has held it in 16 quarters since. The position peaked at $603K in Q4 2024. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

  • Bridgeway Capital Management held 11,035 shares of Biodesix worth $160K as of Q1 2026.
  • Biodesix was a new Bridgeway Capital Management position in Q1 2026.
  • Biodesix made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q1 2026, its #1069 holding.
  • Bridgeway Capital Management first reported a position in Biodesix in Q4 2021 and has held it in 16 quarters since.
  • Bridgeway Capital Management's Biodesix position peaked at $603K in Q4 2024.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.